Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Clinical trial NCT01907854 · COMPLETED
Trial details
- NCT number
- NCT01907854
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2015-06-15
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.